Nuvalent filed a new drug application for an experimental non-small cell lung cancer treatment with the Food and Drug Administration.

Targeted therapies, guided by molecular testing, offer significant benefits, including fewer side effects and personalization ...

At the recent CURE Educated Patient® Lung Cancer Summit, held in tandem with the 2025 PER® New York Lung Cancer Symposium, Dr ...

The FDA announced accelerated approval of sevabertinib (Hyrnuo) for HER2-positive non-small cell lung cancer (NSCLC).

Treatment innovations in advanced lung cancer and melanoma over the past 2 decades have significantly improved OS, but they ...

Amgen's Imdelltra received full approval from the Food and Drug Administration for use in patients with lung cancer. The biotechnology company said Wednesday Imdelltra received approval for adult ...

Living with lung cancer often means spending more time in waiting rooms than in the moments that matter, but a new South ...

Nuvalent said Monday almost a third of patients with a hard-to-treat form of lung cancer responded to its experimental ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

Lung cancer is the leading cause of cancer-related deaths in the United States. As we start Lung Cancer Awareness Month, a new report shows where we stand on fighting against the disease, including ...

Joanne Cure, 78, survived stage 4 lung cancer after being given two years to live, crediting her faith, determination, and ...

This summer, 75-year-old Antioch Township Treasurer and Mesick resident Kathy Soerries was preparing for a family vacation to ...